1. Home
  2. EVGN vs MCVT Comparison

EVGN vs MCVT Comparison

Compare EVGN & MCVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVGN
  • MCVT
  • Stock Information
  • Founded
  • EVGN 1999
  • MCVT 2007
  • Country
  • EVGN Israel
  • MCVT United States
  • Employees
  • EVGN N/A
  • MCVT N/A
  • Industry
  • EVGN Agricultural Chemicals
  • MCVT Finance Companies
  • Sector
  • EVGN Industrials
  • MCVT Finance
  • Exchange
  • EVGN Nasdaq
  • MCVT Nasdaq
  • Market Cap
  • EVGN 15.8M
  • MCVT 14.7M
  • IPO Year
  • EVGN N/A
  • MCVT N/A
  • Fundamental
  • Price
  • EVGN $2.68
  • MCVT $1.98
  • Analyst Decision
  • EVGN Strong Buy
  • MCVT
  • Analyst Count
  • EVGN 1
  • MCVT 0
  • Target Price
  • EVGN $12.00
  • MCVT N/A
  • AVG Volume (30 Days)
  • EVGN 25.1K
  • MCVT 136.5K
  • Earning Date
  • EVGN 11-13-2024
  • MCVT 11-15-2024
  • Dividend Yield
  • EVGN N/A
  • MCVT N/A
  • EPS Growth
  • EVGN N/A
  • MCVT N/A
  • EPS
  • EVGN N/A
  • MCVT 0.04
  • Revenue
  • EVGN $9,449,000.00
  • MCVT $3,248,401.00
  • Revenue This Year
  • EVGN $173.12
  • MCVT N/A
  • Revenue Next Year
  • EVGN $33.10
  • MCVT N/A
  • P/E Ratio
  • EVGN N/A
  • MCVT $55.23
  • Revenue Growth
  • EVGN 290.29
  • MCVT N/A
  • 52 Week Low
  • EVGN $2.29
  • MCVT $1.86
  • 52 Week High
  • EVGN $10.40
  • MCVT $3.88
  • Technical
  • Relative Strength Index (RSI)
  • EVGN 41.14
  • MCVT 34.71
  • Support Level
  • EVGN $2.48
  • MCVT $1.86
  • Resistance Level
  • EVGN $2.87
  • MCVT $2.20
  • Average True Range (ATR)
  • EVGN 0.28
  • MCVT 0.18
  • MACD
  • EVGN 0.03
  • MCVT -0.05
  • Stochastic Oscillator
  • EVGN 37.38
  • MCVT 17.92

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.

About MCVT Mill City Ventures III Ltd.

Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions primarily to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that they provide are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.

Share on Social Networks: